Company profile
GlycoVaxyn company profile
GlycoVaxyn AG, a vaccine biopharmaceutical company, develops and manufactures biological conjugation vaccines against bacterial infections utilizing recombinant DNA technology. It develops and produces immunogenic glycoprotein conjugates vaccines for a range of bacterial diseases, such as pneumococcal and nosocomial infections.
Business identity
- Website
- http://www.glycovaxyn.com/
- Phone number
- +41447338585
- Operating status
- Closed
- Company type
- For Profit
- Employee range
- 11-50 employees
- Founded
- 2004-01-01, Year
Headquarters
- Headquarters
- Schlieren, Zurich, Switzerland
- Postal code
- 8952
- Country code
- CH
- Continent
- Europe